Carl Zeiss Aug 21, 2025 European Commission issues CE mark for Zeiss CIRRUS PathFinder AI tool - Ophthalmology Times Europe
Shanghai Macklin Biochemical Technology Co., Ltd Aug 21, 2025 Natural dual inhibitor isorhamnetin-3-O-neohespeidoside targets tyrosinase and MC1R for skin pigmentation management - Nature
Thermo Fisher Aug 21, 2025 Thermo Fisher Scientific Opens Manufacturing Center of Excellence Site in North Carolina - Business Wire #Fisher Scientific #Scientific Opens
Thermo Fisher Aug 21, 2025 Governor Stein Underscores North Carolina’s Leadership in Biotech Industry at Thermo Fisher Scientific Ribbon-Cutting Ceremony - NC Governor (.gov) #Stein Underscores #Underscores North
Lonza News Aug 20, 2025 Lonza to Highlight Preservation and Disinfection Solutions - Nonwovens Industry - #Nonwovens Industry #Highlight Preservation
10x Genomics Blog Aug 19, 2025 10x Genomics Launches Xenium Protein, Advancing Spatial Biology by Enabling Same-Cell RNA and Protein Analysis - PR Newswire #Genomics Launches #Advancing Spatial
Illumina Aug 19, 2025 Nilesh Shah joins Illumina as Head of Region, AMEA - PR Newswire #Nilesh Shah #Shah joins
Cytiva (Google News) Aug 18, 2025 Biotech Innovation 2025: How Cytiva Is Transforming Drug Development - BioTecNika #Transforming Drug #Biotech Innovation
Beijing Solarbio Science & Technology Co.,Ltd. Aug 18, 2025 Ghrelin’s potential as a therapeutic target for chronic inflammatory diseases: evidence from human endometrial stromal cells - Frontiers
Waters Aug 18, 2025 Waters Corporation’s SWOT analysis: stock poised for growth amid acquisition - Investing.com #SWOT analysis #Waters Corporation
Lonza News Aug 17, 2025 Lonza Stover Obituary (2025) - St. Petersburg, Florida - Tampa Bay Times - Legacy | Obituary #Tampa Bay #Bay Times
Blue Clean Aug 15, 2025 Russia to launch 75 mice, 1,000 fruit flies on Aug. 20 to study spaceflight effects - Space
Schrödinger Aug 14, 2025 Schrödinger stops development of blood cancer therapy after two patient deaths - Reuters
Schrödinger Aug 14, 2025 Schrödinger Halts Cancer Drug Program after Two Patients Die in Phase I Trial - Genetic Engineering and Biotechnology News
Schrödinger Aug 14, 2025 Schrödinger pipeline shrinks to two clinical assets | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
Schrödinger Aug 14, 2025 Schrödinger ends development of blood cancer drug after patient deaths - Clinical Trials Arena